Mikusu India Acquires Shares of Daikaffil Chemicals from Open Market
Mikusu India Private Limited has acquired an additional 6,530 equity shares of Daikaffil Chemicals India Limited on June 05, 2026. The purchase was executed through the open market.The acquisition resulted in Mikusu India increasing its holding in Daikaffil Chemicals India Ltd. While pre-acquisition, Mikusu held 29,19,240 shares, representing 48.66% of the total voting capital. Following the transaction, the holding stood at 29,25,770 shares, translating to a 48.76% stake in the company.
Mikusu India Private Limited is categorized as belonging to the Promoter/Promoter group concerning its investment in Daikaffil Chemicals India Ltd.
The details of the acquisition and resulting shareholdings are summarized below:
| Metric | Details Before Acquisition | Details After Acquisition |
|---|---|---|
| Total Shares Held | 29,19,240 | 29,25,770 |
| Percentage of Voting Capital | 48.66% | 48.76% |
| Acquisition Details | N/A | Acquired 6,530 shares (0.11%) from Open Market on June 05, 2026 |
Financial details of the target company's capital are as follows:
| Financial Aspect | Pre-Acquisition Status | Post-Acquisition Status |
|---|---|---|
| Equity Share Capital | Rs. 6,00,00,000/- (60,00,000 equity shares of Rs. 10 each) | Rs. 6,00,00,000/- (60,00,000 equity shares of Rs. 10 each) |
| Total Diluted Share/Voting Capital | N/A | Rs. 6,00,00,000/- (60,00,000 equity shares of Rs. 10 each) |
The acquisition reflects the ongoing interest of Mikusu India Private Limited in Daikaffil Chemicals India Ltd.
Stock Price Movement
Daikaffil Chemicals India Ltd. settled on Friday after the shares edged higher, finishing at ₹38.67 following a 9.98% climb. Throughout the trading session, the stock demonstrated volatility, moving between an intraday high of ₹38.67 and a low of ₹37.13.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.